Sinsin Pharmaceutical Co. Ltd Capital Reinvestment Ratio
Sinsin Pharmaceutical Co. Ltd capital reinvestment ratio. Sinsin Pharmaceutical Co. Ltd (002800) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.70 Billion) in capital expenditures (₩871.54 Million). Check Sinsin Pharmaceutical Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sinsin Pharmaceutical Co. Ltd (2015–2024)
Capital reinvestment ratio of Sinsin Pharmaceutical Co. Ltd from 2015 to 2024. This chart tracks Sinsin Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore net asset growth rate of Sinsin Pharmaceutical Co. Ltd to track the company's year-over-year net asset growth rate.
Sinsin Pharmaceutical Co. Ltd Capital Reinvestment Ratio by Year (2015–2024)
Sinsin Pharmaceutical Co. Ltd capital reinvestment ratio by year from 2015 to 2024. For the full cash flow conversion analysis, see Sinsin Pharmaceutical Co. Ltd (002800) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩5.94 Billion | ₩1.51 Billion | ▼ -80.1% |
| 2023 | 1.28x | ₩3.93 Billion | ₩5.03 Billion | ▲ +670.0% |
| 2022 | 0.17x | ₩5.46 Billion | ₩907.13 Million | ▼ -99.9% |
| 2021 | 115.70x | ₩23.18 Million | ₩2.68 Billion | ▲ +1702.9% |
| 2020 | 6.42x | ₩1.87 Billion | ₩11.97 Billion | ▼ -80.5% |
| 2018 | 32.86x | ₩774.24 Million | ₩25.44 Billion | ▲ +4103.1% |
| 2017 | 0.78x | ₩4.57 Billion | ₩3.57 Billion | ▼ -70.6% |
| 2016 | 2.66x | ₩2.79 Billion | ₩7.43 Billion | ▲ +166.7% |
| 2015 | 1.00x | ₩5.24 Billion | ₩5.22 Billion | — |